Sukumar Nagendran - 13 Dec 2022 Form 4 Insider Report for Solid Biosciences Inc. (SLDB)

Role
Director
Signature
/s/ by David Tyronne Howton as attorney-in-fact for Sukumar Nagendran
Issuer symbol
SLDB
Transactions as of
13 Dec 2022
Net transactions value
$0
Form type
4
Filing time
15 Dec 2022, 17:07:44 UTC
Previous filing
22 Jun 2022
Next filing
04 Jan 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SLDB Director Stock Option (Right to Buy) Award $0 +9,650 $0.000000 9,650 13 Dec 2022 Common Stock 9,650 $6.47 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was granted on December 13, 2022 and vests in full on the one-year anniversary of the grant date, and will vest automatically as to 100% of the unvested portion of such option upon specified change in control events.

Remarks:

Exhibit Index: 24.1 Power of Attorney